vs
Cronos Group Inc.（CRON）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
Cronos Group Inc.的季度营收约是RBB Bancorp的1.4倍（$44.5M vs $32.3M），RBB Bancorp净利率更高（31.5% vs -4.1%，领先35.6%），Cronos Group Inc.同比增速更快（47.0% vs 12.6%），RBB Bancorp自由现金流更多（$42.6M vs $9.7M），过去两年Cronos Group Inc.的营收复合增速更高（32.7% vs 7.0%）
Cronos集团是全球性大麻素企业，主营大麻种植、加工及相关衍生产品的分销业务，产品线覆盖健康补充剂、快消品及医用大麻品类，主要服务北美、欧洲、亚太地区的合规娱乐与医用消费市场，严格遵循各地监管要求保障产品品质。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
CRON vs RBB — 直观对比
营收规模更大
CRON
是对方的1.4倍
$32.3M
营收增速更快
CRON
高出34.4%
12.6%
净利率更高
RBB
高出35.6%
-4.1%
自由现金流更多
RBB
多$32.9M
$9.7M
两年增速更快
CRON
近两年复合增速
7.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $44.5M | $32.3M |
| 净利润 | $-1.8M | $10.2M |
| 毛利率 | 36.4% | — |
| 营业利润率 | -16.8% | 39.5% |
| 净利率 | -4.1% | 31.5% |
| 营收同比 | 47.0% | 12.6% |
| 净利润同比 | -104.2% | 132.1% |
| 每股收益（稀释后） | $-0.01 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRONRBB
| Q4 25 | $44.5M | $32.3M | ||
| Q3 25 | $36.3M | $32.6M | ||
| Q2 25 | $33.5M | $35.8M | ||
| Q1 25 | $32.3M | $28.5M | ||
| Q4 24 | $30.3M | $28.7M | ||
| Q3 24 | $34.3M | $30.3M | ||
| Q2 24 | $27.8M | $27.5M | ||
| Q1 24 | $25.3M | $28.2M |
净利润CRONRBB
| Q4 25 | $-1.8M | $10.2M | ||
| Q3 25 | $26.0M | $10.1M | ||
| Q2 25 | $-39.7M | $9.3M | ||
| Q1 25 | $6.1M | $2.3M | ||
| Q4 24 | $43.7M | $4.4M | ||
| Q3 24 | $8.3M | $7.0M | ||
| Q2 24 | $-8.8M | $7.2M | ||
| Q1 24 | $-2.2M | $8.0M |
毛利率CRONRBB
| Q4 25 | 36.4% | — | ||
| Q3 25 | 50.4% | — | ||
| Q2 25 | 43.4% | — | ||
| Q1 25 | 42.6% | — | ||
| Q4 24 | 35.7% | — | ||
| Q3 24 | 10.5% | — | ||
| Q2 24 | 22.7% | — | ||
| Q1 24 | 17.7% | — |
营业利润率CRONRBB
| Q4 25 | -16.8% | 39.5% | ||
| Q3 25 | -1.4% | 40.7% | ||
| Q2 25 | -15.9% | 36.1% | ||
| Q1 25 | -12.6% | 11.2% | ||
| Q4 24 | -37.5% | 17.6% | ||
| Q3 24 | -98.2% | 31.6% | ||
| Q2 24 | -56.1% | 35.6% | ||
| Q1 24 | -63.1% | 39.9% |
净利率CRONRBB
| Q4 25 | -4.1% | 31.5% | ||
| Q3 25 | 71.4% | 31.2% | ||
| Q2 25 | -118.7% | 26.1% | ||
| Q1 25 | 19.0% | 8.0% | ||
| Q4 24 | 144.3% | 15.3% | ||
| Q3 24 | 24.4% | 23.1% | ||
| Q2 24 | -31.5% | 26.4% | ||
| Q1 24 | -8.9% | 28.4% |
每股收益（稀释后）CRONRBB
| Q4 25 | $-0.01 | $0.59 | ||
| Q3 25 | $0.07 | $0.59 | ||
| Q2 25 | $-0.10 | $0.52 | ||
| Q1 25 | $0.02 | $0.13 | ||
| Q4 24 | $0.12 | $0.26 | ||
| Q3 24 | $0.02 | $0.39 | ||
| Q2 24 | $-0.02 | $0.39 | ||
| Q1 24 | $-0.01 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $831.8M | $212.3M |
| 总债务越低越好 | — | $119.9M |
| 股东权益账面价值 | $1.1B | $523.4M |
| 总资产 | $1.2B | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资CRONRBB
| Q4 25 | $831.8M | $212.3M | ||
| Q3 25 | $824.2M | $234.9M | ||
| Q2 25 | $834.4M | $191.9M | ||
| Q1 25 | $837.8M | $238.8M | ||
| Q4 24 | $858.8M | $257.7M | ||
| Q3 24 | $862.0M | $349.4M | ||
| Q2 24 | $848.2M | $252.8M | ||
| Q1 24 | $855.1M | — |
总债务CRONRBB
| Q4 25 | — | $119.9M | ||
| Q3 25 | — | $119.8M | ||
| Q2 25 | — | $119.7M | ||
| Q1 25 | — | $119.6M | ||
| Q4 24 | — | $119.5M | ||
| Q3 24 | — | $119.4M | ||
| Q2 24 | — | $119.3M | ||
| Q1 24 | — | $119.2M |
股东权益CRONRBB
| Q4 25 | $1.1B | $523.4M | ||
| Q3 25 | $1.1B | $514.3M | ||
| Q2 25 | $1.1B | $517.7M | ||
| Q1 25 | $1.1B | $510.3M | ||
| Q4 24 | $1.1B | $507.9M | ||
| Q3 24 | $1.1B | $509.7M | ||
| Q2 24 | $1.1B | $511.3M | ||
| Q1 24 | $1.1B | $514.0M |
总资产CRONRBB
| Q4 25 | $1.2B | $4.2B | ||
| Q3 25 | $1.2B | $4.2B | ||
| Q2 25 | $1.2B | $4.1B | ||
| Q1 25 | $1.2B | $4.0B | ||
| Q4 24 | $1.2B | $4.0B | ||
| Q3 24 | $1.2B | $4.0B | ||
| Q2 24 | $1.1B | $3.9B | ||
| Q1 24 | $1.1B | $3.9B |
负债/权益比CRONRBB
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.23× | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.8M | $43.4M |
| 自由现金流经营现金流 - 资本支出 | $9.7M | $42.6M |
| 自由现金流率自由现金流/营收 | 21.8% | 131.8% |
| 资本支出强度资本支出/营收 | 4.8% | 2.5% |
| 现金转化率经营现金流/净利润 | — | 4.26× |
| 过去12个月自由现金流最近4个季度 | $149.0K | $73.5M |
8季度趋势，按日历期对齐
经营现金流CRONRBB
| Q4 25 | $11.8M | $43.4M | ||
| Q3 25 | $13.3M | $2.1M | ||
| Q2 25 | $2.8M | $21.7M | ||
| Q1 25 | $-2.1M | $7.8M | ||
| Q4 24 | $7.7M | $58.5M | ||
| Q3 24 | $11.6M | $24.5M | ||
| Q2 24 | $1.7M | $11.7M | ||
| Q1 24 | $-2.2M | $4.8M |
自由现金流CRONRBB
| Q4 25 | $9.7M | $42.6M | ||
| Q3 25 | $8.8M | $1.8M | ||
| Q2 25 | $-1.0M | $21.6M | ||
| Q1 25 | $-17.4M | $7.6M | ||
| Q4 24 | $4.2M | $57.7M | ||
| Q3 24 | $5.2M | $24.2M | ||
| Q2 24 | $1.0M | $11.5M | ||
| Q1 24 | $-3.9M | $4.7M |
自由现金流率CRONRBB
| Q4 25 | 21.8% | 131.8% | ||
| Q3 25 | 24.3% | 5.4% | ||
| Q2 25 | -3.0% | 60.2% | ||
| Q1 25 | -53.8% | 26.7% | ||
| Q4 24 | 13.8% | 201.0% | ||
| Q3 24 | 15.1% | 80.0% | ||
| Q2 24 | 3.7% | 42.0% | ||
| Q1 24 | -15.5% | 16.6% |
资本支出强度CRONRBB
| Q4 25 | 4.8% | 2.5% | ||
| Q3 25 | 12.3% | 1.1% | ||
| Q2 25 | 11.5% | 0.3% | ||
| Q1 25 | 47.3% | 0.6% | ||
| Q4 24 | 11.7% | 2.7% | ||
| Q3 24 | 18.7% | 0.8% | ||
| Q2 24 | 2.6% | 0.5% | ||
| Q1 24 | 6.8% | 0.5% |
现金转化率CRONRBB
| Q4 25 | — | 4.26× | ||
| Q3 25 | 0.51× | 0.21× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | -0.34× | 3.39× | ||
| Q4 24 | 0.18× | 13.34× | ||
| Q3 24 | 1.39× | 3.50× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRON
| Cannabis Flower | $33.7M | 76% |
| Cannabis Extracts | $10.8M | 24% |
RBB
暂无分部数据
